Syndax Pharmaceuticals, Inc. (SNDX)

NMS – Real Time Price. Currency in USD

20.95

+0.54 (2.65%)

Market open: May 13, 2026, 1:53 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

172M

24M

Cost of goods sold

-7M

-834K

-12K

-454K

Gross Profit

165M

23M

-12K

-454K

Operating expenses (excl. COGS)

-438M

-363M

-230M

-151M

Operating Income

-273M

-340M

-230M

-152M

Non-operating income, total

-12M

21M

Pretax income

-285M

-319M

-209M

-149M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-285M

-319M

-209M

-149M

Syndax Pharmaceuticals, Inc. (SNDX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Syndax Pharmaceuticals, Inc. (SNDX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Syndax Pharmaceuticals, Inc. (SNDX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Syndax Pharmaceuticals, Inc. (SNDX)

Income Statement (Annual)

Income Statement (Annual)